ANI Pharma

Forecast & Rating9 analysts currently cover ANI Pharma, with about 77.8% giving a positive rating — meaning they expect the stock to rise. The average price target is $105.78, about 45.8% upside from the current price of $72.57. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 88.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study ANI Pharma closely still see room for the stock to rise. Data as of Oct 6, 2026; for reference only and not investment advice.